Japan’s Aging Population Drives Demand for Orthopedic Medical Devices, HOYA Seeks Cooperation Opportunities in Taiwan

According to Japan's Ministry of Internal Affairs and Communications, the population aged 65 and over in Japan has reached 36.25 million, accounting for 29.3% of the total population. This marks a historic high as the country continues to face rapid aging.

With the development of an aging society, Japan’s demand for orthopedic medical devices has significantly increased, particularly in areas such as artificial joints and bone filling materials.

HOYA, one of Japan's top 10 medical device manufacturers, sees potential in Taiwan's Asian market. The company is actively seeking partnerships in orthopedic medical devices through the Taiwan Healthcare+ Expo in December, aiming to meet market needs through Taiwan-Japan collaboration.

Japan's medical device market continues to grow steadily, with the industry size projected to reach $3.5 billion by 2040. This growth is driven not only by the large aging population but also by Japan's advanced medical infrastructure and health care needs, making it a hotspot for international medical device companies.

According to BMI Research, Japan is the third-largest medical device market globally, valued at over USD 28 billion. As demand continues to rise, HOYA, known for its scale and reputation in orthopedic medical devices, aims to innovate in bone filling materials and implantable medical devices while enhancing its presence in the Asian market.

Both Taiwan and Japan share the Asian market, where orthopedic device designs are better suited to the needs of Asian populations compared to those from Europe and the U.S. In the past, orthopedic devices in Asia primarily relied on Western products, which often failed to fully accommodate the unique curvatures of Asian bones. Now, Japan and Taiwan are starting to customize products specifically for the Asian market. HOYA's advanced technical expertise, combined with Taiwan's responsive market insights and flexible production capacity, create a significant competitive advantage for their collaboration.

Taiwan has long maintained a stable supply relationship with Japan in the medical device market, with Japan being Taiwan's third-largest export market for medical devices. In 2023, Taiwan exported USD 281 million worth of medical devices to Japan, showing steady growth year after year. HOYA's further involvement provides Taiwanese companies with additional opportunities to access international markets, particularly in orthopedic materials and implantable medical device manufacturing. Taiwanese companies can take advantage of this opportunity to strengthen their position in the Japanese market and expand into broader international markets by leveraging HOYA's brand recognition.

Also Want to Explore More Business Opportunities?

【Register for the 2024 Heathcare+ Expo Now to Find the Best Partners! ▸】